Anne R. Gocke

1.8k total citations
28 papers, 1.5k citations indexed

About

Anne R. Gocke is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Anne R. Gocke has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Anne R. Gocke's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Anne R. Gocke is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Anne R. Gocke collaborates with scholars based in United States, Canada and Germany. Anne R. Gocke's co-authors include Amy E. Lovett‐Racke, Peter A. Calabresi, Michael K. Racke, Rehana Z. Hussain, Inna V. Grishkan, Petra D. Cravens, Li-Hong Ben, Achilles Ntranos, Thomas Kodadek and Haiyan Peng and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anne R. Gocke

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne R. Gocke United States 19 639 562 420 188 184 28 1.5k
Ulf Schulze‐Topphoff United States 16 814 1.3× 711 1.3× 581 1.4× 293 1.6× 200 1.1× 22 2.0k
Belinda J. Kaskow United States 11 393 0.6× 496 0.9× 384 0.9× 333 1.8× 139 0.8× 13 1.3k
Bernadette Kálmán United States 26 483 0.8× 932 1.7× 723 1.7× 279 1.5× 214 1.2× 83 2.0k
Jessica E. Kenison United States 15 786 1.2× 569 1.0× 136 0.3× 471 2.5× 155 0.8× 15 1.8k
Joost Drexhage Netherlands 22 417 0.7× 827 1.5× 472 1.1× 687 3.7× 357 1.9× 27 2.0k
Ajaib S. Paintlia United States 21 327 0.5× 510 0.9× 175 0.4× 262 1.4× 158 0.9× 29 1.3k
Miguel Lucas Spain 23 407 0.6× 807 1.4× 338 0.8× 114 0.6× 215 1.2× 87 1.9k
Peter Heining Switzerland 10 320 0.5× 1.1k 1.9× 339 0.8× 188 1.0× 121 0.7× 13 1.6k
Simon Faissner Germany 20 215 0.3× 304 0.5× 534 1.3× 265 1.4× 180 1.0× 61 1.3k
Stéphanie Zandee Canada 18 404 0.6× 438 0.8× 188 0.4× 471 2.5× 89 0.5× 33 1.2k

Countries citing papers authored by Anne R. Gocke

Since Specialization
Citations

This map shows the geographic impact of Anne R. Gocke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne R. Gocke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne R. Gocke more than expected).

Fields of papers citing papers by Anne R. Gocke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne R. Gocke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne R. Gocke. The network helps show where Anne R. Gocke may publish in the future.

Co-authorship network of co-authors of Anne R. Gocke

This figure shows the co-authorship network connecting the top 25 collaborators of Anne R. Gocke. A scholar is included among the top collaborators of Anne R. Gocke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne R. Gocke. Anne R. Gocke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Coyle, Patricia K., et al.. (2021). Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era. Advances in Therapy. 38(7). 3550–3588. 26 indexed citations
4.
Liu, Lijuan, John A. Fissel, Aniqa Tasnim, et al.. (2016). Increased TNFR1 expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity. Neurobiology of Disease. 93. 21–27. 9 indexed citations
5.
Baxi, Emily G., Inna V. Grishkan, Matthew D. Smith, et al.. (2015). Transfer of Myelin-Reactive Th17 Cells Impairs Endogenous Remyelination in the Central Nervous System of Cuprizone-Fed Mice. Journal of Neuroscience. 35(22). 8626–8639. 81 indexed citations
6.
Bhargava, Pavan, Elias S. Sotirchos, Christopher Eckstein, et al.. (2015). High-dose vitamin D supplementation reduces IL-17-producing CD4+ T-cells and effector-memory CD4+ T-cells in multiple sclerosis patients (S38.001). Neurology. 84(14_supplement). 7 indexed citations
7.
Sotirchos, Elias S., Pavan Bhargava, Christopher Eckstein, et al.. (2015). Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology. 86(4). 382–390. 104 indexed citations
8.
Bhargava, Pavan, Anne R. Gocke, & Peter A. Calabresi. (2015). 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. Journal of Neuroimmunology. 279. 20–24. 10 indexed citations
9.
Osborne, Lauren M., et al.. (2015). Increased inflammatory markers in late pregnancy depression: The role of progesterone and allopregnanolone. Brain Behavior and Immunity. 49. e22–e23. 1 indexed citations
10.
Grishkan, Inna V., et al.. (2013). 1,25-Dihydroxyvitamin D 3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences. 110(52). 21101–21106. 44 indexed citations
11.
Hu, Lina, Tongguang Wang, Anne R. Gocke, et al.. (2013). Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes. PLoS ONE. 8(1). e54267–e54267. 29 indexed citations
12.
Grishkan, Inna V., Achilles Ntranos, Peter A. Calabresi, & Anne R. Gocke. (2013). Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cellular Immunology. 284(1-2). 68–74. 33 indexed citations
13.
Reddy, M. Muralidhar, Rosemary Wilson, Anne R. Gocke, et al.. (2011). Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening. Cell. 144(1). 132–142. 167 indexed citations
14.
Hu, Lina, Anne R. Gocke, Jason M. Rosenzweig, et al.. (2011). Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling. Journal of Biological Chemistry. 287(2). 1261–1268. 28 indexed citations
15.
Gocke, Anne R., et al.. (2009). Isolation of Antagonists of Antigen-Specific Autoimmune T Cell Proliferation. Chemistry & Biology. 16(11). 1133–1139. 24 indexed citations
16.
Yang, Yuhong, Yue Liu, Ping Wei, et al.. (2009). Silencing Nogo‐A promotes functional recovery in demyelinating disease. Annals of Neurology. 67(4). 498–507. 63 indexed citations
17.
Yang, Yuhong, Anne R. Gocke, Amy E. Lovett‐Racke, Paul D. Drew, & Michael K. Racke. (2008). PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis. PPAR Research. 2008(1). 546753–546753. 41 indexed citations
18.
Gocke, Anne R., Petra D. Cravens, Li-Hong Ben, et al.. (2007). T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity. The Journal of Immunology. 178(3). 1341–1348. 216 indexed citations
19.
Racke, Michael K., Anne R. Gocke, Mark T. Muir, et al.. (2006). Nuclear Receptors and Autoimmune Disease: The Potential of PPAR Agonists to Treat Multiple Sclerosis. Journal of Nutrition. 136(3). 700–703. 43 indexed citations
20.
Lovett‐Racke, Amy E., Petra D. Cravens, Anne R. Gocke, Michael K. Racke, & Olaf Stüve. (2005). Therapeutic Potential of Small Interfering RNA for Central Nervous System Diseases. Archives of Neurology. 62(12). 1810–1810. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Schulze‐Topphoff Breakdown of academic impact, for papers by Belinda J. Kaskow Breakdown of academic impact, for papers by Bernadette Kálmán Breakdown of academic impact, for papers by Jessica E. Kenison Breakdown of academic impact, for papers by Joost Drexhage Breakdown of academic impact, for papers by Ajaib S. Paintlia Breakdown of academic impact, for papers by Miguel Lucas Breakdown of academic impact, for papers by Peter Heining Breakdown of academic impact, for papers by Simon Faissner Breakdown of academic impact, for papers by Stéphanie Zandee
Rankless by CCL
2026